Skip to main content
Caplight Logo









Numeric Biotech

Numeric Biotech

Private
RotterdamHealthcare & Life Scienceshttps://www.numericbiotech.com/

Last Round

Seed

Apr 26, 2018

Total Funding Raised

$368,000

Company Overview

Numeric Biotech is a biotechnology company that develops senolytic therapies to treat and prevent age-related diseases and chronic inflammation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

senolytic therapysenescent cellsFOXO4-DRIanti-aging medicinelongevity biotechpeptide therapeuticsdrug discoveryage-related diseasechronic inflammationpreclinical researchbiopharmaceuticalhealthspan extensioncellular healthout-licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Numeric Biotech Comparables

Compare Numeric Biotech with similar companies based on industry and business-model similarity.

Numeric Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cleara Biotech
87%
Rubedo Life Sciences
79%
Centenara Labs AG
79%

Numeric Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 26, 2018

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 26, 2018

    $368K raised from uniiq and Erasmus MC.

Numeric Biotech Filings

Explore SEC and related filing metadata, where available.

Numeric Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Numeric Biotech's valuation, stock price, and market status.

Is Numeric Biotech a public or private company?

Numeric Biotech is a private company.

What is the current stock price of Numeric Biotech?

Numeric Biotech is a private company with no public stock price. No recent secondary market data is available.

How much is Numeric Biotech worth (valuation)?

Valuation information for Numeric Biotech is not publicly available.

Can I buy Numeric Biotech stock?

Numeric Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Numeric Biotech's last funding round?

Numeric Biotech's most recent funding round was Seed on April 26, 2018.

Who are the main investors in Numeric Biotech?

Investor information for Numeric Biotech is not publicly disclosed.

Will Numeric Biotech IPO soon?

No public IPO plans have been announced for Numeric Biotech.

How can I track Numeric Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Numeric Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersRotterdam
Year Founded2017
Last FundingApr 26, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?